SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-034475
Filing Date
2023-10-17
Accepted
2023-10-17 08:37:35
Documents
15
Period of Report
2023-10-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K csbr-20231009.htm   iXBRL 8-K 35084
2 EX-99.1 csbr10172023ex991xappointi.htm EX-99.1 8750
7 GRAPHIC logobranding_headerleftali.jpg GRAPHIC 32167
  Complete submission text file 0001628280-23-034475.txt   216033

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20231009.xsd EX-101.SCH 2186
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20231009_def.xml EX-101.DEF 2872
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20231009_lab.xml EX-101.LAB 23109
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20231009_pre.xml EX-101.PRE 12628
9 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20231009_htm.xml XML 2446
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 231328516
SIC: 2836 Biological Products, (No Diagnostic Substances)